Analysis of metabolic response (MR) by positron emission tomography (PET) compared with tumor response by computed tomography (CT) from MPACT, a phase III trial comparing nab-paclitaxel (nab-P) plus gemcitabine (G) versus G alone for patients (pts) with metastatic adenocarcinoma of the pancreas

被引：0

作者：

Ramanathan, Ramesh K.

Von Hoff, Daniel D.

Moore, Malcolm J.

Teixeira, Luis

Siena, Salvatore

Tabernero, Josep

Goldstein, David

Wei, Xinyu

Lu, Brian

机构：

[1] Virginia G Piper Canc Ctr, Translat Genom Res Inst, Scottsdale, AZ USA

[2] Scottsdale Healthcare TGen, Virginia G Piper Canc Ctr Clin Trials, Scottsdale, AZ USA

[3] Princess Margaret Hosp, Toronto, ON M4X 1K9, Canada

[4] Hop St Antoine, F-75571 Paris, France

[5] Osped Niguarda Ca Granda, Falck Div Med Oncol, Milan, Italy

[6] Vall dHebron Univ Hosp, Barcelona, Spain

[7] Prince Wales Hosp, Sydney, NSW, Australia

[8] Celgene Corp, Summit, NJ USA

来源：

关键词：

D O I：

10.1200/jco.2014.32.3_suppl.254

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

254

引用

页数：1

共 42 条